Award Date
5-15-2026
Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Department
Chemistry and Biochemistry
First Committee Member
Hui Zhang
Second Committee Member
Hong Sun
Third Committee Member
Gary Kleiger
Fourth Committee Member
Edwin Oh
Number of Pages
172
Abstract
The SRY (Sex-determining Region Y) protein is a transcription factor encoded on the Y chromosome and is the key regulator responsible for initiating male sex determination in mammals. During early embryonic development, SRY activates the genetic program that leads to testis formation by promoting the expression of downstream genes involved in male gonadal differentiation. Mutations or dysregulation of SRY can lead to disorders of sex development such as male-to-female sex conversion and hermaphroditism, highlighting its critical role in sex determination.
SRY belongs to the SOX (SRY-related HMG-box) family of transcription factors, which includes the proteins SOX1, SOX2 and SOX3. These proteins share a highly conserved highmobility group (HMG) DNA-binding domain, which allows them to bind and bend DNA to regulate transcription. Functionally, SOX1, SOX2 and SOX3 play major roles in embryonic development and cell fate determination, particularly in the maintenance and differentiation of neural progenitor cells. SOX2 is especially known for its role in maintaining pluripotency and self-renewal in embryonic stem cells, whereas SOX1 and SOX3 are primarily involved in neural development and central nervous system formation. SOX2 amplification was found to be closely related to many cancers, including lung, esophagus, and oral cavity, and small cell lung carcinomas and glioblastoma multiforme. SOX2 is over-expressed in many poorly differentiated and aggressive cancers, including breast, ovarian, gastric, and colon carcinomas. Mutations or dysregulation of the SOX1 protein cause neurodevelopmental disorders and epilepsy, and mutations or deletions of the SOX3 protein causes X-linked hypopituitarism and intellectual disabilities due to impaired neural and pituitary development.
SRY and SOX1-3 proteins contain a conserved motif that is methylated by the SET7 methyltransferase and demethylated by LSD1, lysine-specific histone demethylase 1A. siRNAmediated knockdown of human LSD1 protein and mouse Lsd1 knockouts destabilized the human and mouse SOX1-3 proteins and human SRY protein indicating that LSD1 is crucial to maintain the stability of the SOX family proteins. Methylated lysine residues of the SOX family proteins are bound by the methyl-binding protein L3MBTL3, and they are targeted for proteolytic degradation via the proteasome. Loss of L3MBTL3 in human cells that are deficient in LSD1 and mouse L3mbtl3 knockouts re-stabilized the target substrates suggesting that L3MBTL3 is required for the degradation of the SOX family proteins. DCAF5 is a substrate specific receptor of the CRL4 E3 ubiquitin ligase complex that polyubiquitinates substrates and targets them for degradation. Silencing DCAF5 in human cancer cells lacking LSD1, and homozygous deletion of Dcaf5 in mice caused the stabilization of the SOX family proteins. These in vitro and in vivo assays for SRY and SOX1-3 proteins showed that the stability of these proteins are dynamically regulated in a methylation-dependent manner. We are proposing a methylation-dependent regulatory pathway that control the stability of these critical proteins for maintaining cellular identity and functional integrity.
Keywords
Methylation; Protein regulation; Protein stability; SOX2; SRY
Disciplines
Chemistry | Genetics and Genomics | Life Sciences
File Format
File Size
23500 KB
Degree Grantor
University of Nevada, Las Vegas
Language
English
Repository Citation
Rajawasam, Keshari Gayathri, "Methylation-Dependent Regulatory Pathway That Governs the Stability of the Sox Family Proteins and Related Developmental Regulators" (2026). UNLV Theses, Dissertations, Professional Papers, and Capstones. 5614.
https://oasis.library.unlv.edu/thesesdissertations/5614
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/